ZETRON Injection contains Granisetron 1 mg/ml, a 5-HT3 receptor antagonist that effectively prevents nausea and vomiting caused by:
Chemotherapy (CINV) – Prevents nausea due to cancer treatment
Radiotherapy (RINV) – Controls radiation-induced vomiting
Post-Surgery (PONV) – Reduces nausea after anesthesia and surgery
Indications
Cancer Treatment Support – Prevents nausea during chemotherapy/radiotherapy
Postoperative Care – Controls vomiting after surgery or anesthesia
Emergency Anti-Nausea Solution – Rapid action for severe vomiting episodes
Dosage & Administration
Recommended Dosage:
Chemotherapy-Induced Nausea (CINV): 1 mg IV before chemotherapy
Radiotherapy-Induced Nausea (RINV): 1 mg IV once daily
Postoperative Nausea (PONV): 1 mg IV before anesthesia
Administered by healthcare professionals only!
Precautions & Warnings
Use with Caution in Patients with Heart Conditions – May cause QT prolongation.
Not for Pediatric Use Without Medical Supervision.
Potential Side Effects: Headache, constipation, dizziness, or allergic reactions.
Why Choose ZETRON Injection?
Rapid-Action Nausea Relief – Works within minutes
Long-Lasting Protection – Prevents vomiting for up to 24 hours
Essential for Cancer & Post-Surgical Patients
Clinically Proven 5-HT3 Receptor Antagonist
ZETRON Injection (Granisetron 1 mg/ml) is an essential solution for managing chemotherapy, radiotherapy, and postoperative nausea. Its fast action and long-lasting protection make it a trusted choice in hospitals and oncology care.
Consult your doctor before use!
Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.
For more such product information and similar product category Injectables
You can also contact us https://www.zodakhealthcare.com/contact-us/
